Clinical Trial Update: Topotecan Episcleral Plaque for Treatment of Retinoblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating topotecan delivered via an episcleral plaque for retinoblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Topotecan episcleral plaque (Topotecan)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Retinoblastoma | Phase 1 | Status: COMPLETED